The EUnetHTA planned assessment of transcatheter aortic valve implantation (TAVI) in patients with aortic stenosis at intermediate surgical risk

Italian national health technology assessment agency (Agenas) and Norwegian Institute of Public Health (NIPHO) will jointly perform a rapid assessment of transcatheter aortic valve implantation (TAVI) within EUnetHTA framework. The objective of the work will be dedicated to rapid assessment of TAVI procedure in patients with aortic stenosis at intermediate risk compared to aortic valve replacement in relation to efficacy and safety. Another purpose is a development of more than two national or local reports with results of assessment.

Some of HTA bodies and external experts from Belgium, Greece, Ireland and Switzerland will carry out a review of the draft and the final version of the assessment report.

Analysis of efficacy is planned via review of randomized controlled trials (RCTs). Safety will be evaluated within the review of RCTs and real-world evidence data.

In accordance to planned activities first draft of assessment will be ready to review till 20th of November and final version will prepared till 31st of January, 2018.

See full plan in English here.

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.